Full Text View
Tabular View
No Study Results Posted
Related Studies
Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma
This study has been completed.
Study NCT00078637   Information provided by Eisai Inc.
First Received: March 3, 2004   Last Updated: August 23, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neoplasms
Lymphoma, Malignant
Additional conditions recognized in this trial
Lymphoma
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Interventions listed in this trial
E7820
Sponsors listed in this trial
Eisai Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services